Hemolytic anemia due to acute cytomegalovirus infection in an immunocompetent adult: a case report and review of the literature by Fabrizio Taglietti et al.
CASE REPORT Open Access
Hemolytic anemia due to acute cytomegalovirus
infection in an immunocompetent adult:
a case report and review of the literature
Fabrizio Taglietti*, Cecilia M Drapeau, Elisabetta Grilli, Alessandro Capone, Pasquale Noto, Simone Topino,
Nicola Petrosillo
Abstract
Introduction: Cytomegalovirus is a common virus responsible for a wide range of clinical manifestations.
Hemolysis is a rare but potentially life-threatening complication of cytomegalovirus infection, described mostly in
immunocompromised patients, the pathogenesis of which is still unclear.
We performed a review of the literature regarding cases of hemolytic anemia during acute cytomegalovirus infec-
tion in apparently immunocompetent individuals. We searched for relevant articles in PubMed for the period of
1980 through 2008.
Case presentation: We describe a case of Coombs-negative hemolytic anemia in a 44-year-old Caucasian
immunocompetent man with acute cytomegalovirus infection.
Conclusion: Clinicians should consider cytomegalovirus infection in the differential diagnosis of hemolytic anemia
in immunocompetent adults. Possible therapeutic options include antiviral therapy and steroids, although the best
treatment strategy is still controversial.
Introduction
Cytomegalovirus (CMV) is a common viral agent
responsible for a wide range of clinical manifestations
that vary according to the immunologic status of the
patient. In the immunocompetent adult patient, primary
CMV infection is generally asymptomatic or occurs as a
mononucleosis-like self-limited syndrome. In immuno-
compromised patients, CMV infection can lead to severe
clinical manifestations related to direct viral cytotoxic
effect on specific organs and tissues (gastrointestinal
tract, central nervous system, retina, respiratory tract,
and hematopoietic system). In patients with transplants,
CMV is responsible for allograft rejection and opportu-
nistic infection. Finally, CMV infection has been also
associated with other manifestations, including hemoly-
tic anemia [1-3].
Severe hemolysis is a rare but potentially life-threatening
complication of CMV infection described mostly in
immunocompromised adults [1-3] and children [4]. The
pathogenesis of hemolytic anemia during CMV infection
is still unclear, although it has been hypothesized to be the
result of immunologic activation [1-3]. Hemolytic anemia
is rarely described in immunocompetent adults [1-3,5-8].
We describe a Coombs-negative hemolytic anemia in
an adult immunocompetent patient with acute CMV
infection.
Case presentation
A 44-year-old Caucasian man, without any relevant past
medical history, was admitted to our Infectious Diseases
Hospital because of a 30-day history of fever and pro-
gressive asthenia. Fifteen days earlier, the patient was
hospitalized in an Emergency Medical Department,
where acute CMV infection was diagnosed (positive
CMV IgM, negative CMV IgG, CMV viremia, 12,698
copies/mL). Other tests showed alanine aminotransfer-
ase (ALT), 47 U/L (normal value, < 40); aspartate ami-
notransferase (AST), 71 U/L (n.v., < 40); alkaline
phosphatase (ALP), 304 U/L (n.v., < 130 U/L); and lac-
tate dehydrogenase (LDH), 600 U/L (n.v., < 500 U/L).
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Mild anemia was present: hemoglobin (Hb), 11.3 g/dL;
and increased inflammatory indexes: C-reactive protein,
30.9 mg/L (n.v., < 6), erythrocyte sedimentation rate
(ESR), 19 mm/h. No antiviral treatment was started
because the patient was immunocompetent.
After hospital discharge, the fever persisted, and the
patient complained of progressive asthenia.
At admission to our hospital, the patient appeared
pale and asthenic. Physical examination revealed a body
temperature of 38°C, heart rate of 100 beats per minute,
and moderate hepatosplenomegaly. The blood examina-
tions showed acute hemolytic anemia: red blood cells
(RBCs), 2,430,000/mm3; Hb, 7.9 g/dL; reticulocyte
count, 16.7%; LDH, 778 mU/mL; total bilirubin, 2.4 mg/
dL; indirect bilirubin, 2 mg/dL; and undetectable serum
haptoglobin.
Noninfectious causes of hemolytic anemia, including
hemoglobinopathies (such as glucose-6-phosphate dehy-
drogenase deficiency), drug toxicity, autoimmune dis-
eases, and malignancies, were excluded. Of note, direct
and indirect Coombs tests were negative, although mildly
positive for cold agglutinins and cryoglobulins. A total-
body computed tomography scan was negative for solid
tumors, revealing only moderate hepatosplenomegaly.
Serologic and virologic examinations showed CMV
IgM/IgG, positive; CMV antigenemia, negative; CMV
viremia, positive (< 400 cp/mL); parvovirus B19 IgM/
IgG, positive, with blood polymerase chain reaction
(PCR) negative; and EBV VCA IgM/IgG, positive, with
blood PCR negative. Blood cultures, antibodies to HIV,
hepatitis B and C virus, human herpesvirus-6, herpes
simplex virus 1-2, Toxoplasma, Mycoplasma, Legionella,
and hepatitis B surface antigen were negative.
The clinical picture was attributed to primary CMV
infection. The Hb level was 6.7 g/dL at day four and
decreased to 5.4 g/dL at day seven. The patient
remained febrile. Considering the rapid decrease of Hb
levels, specific antiviral treatment with ganciclovir, 900
mg/day (5 mg/kg/b.i.d., i.v.) was administered to the
patient. After hematologic consultation, blood transfu-
sions were prescribed.
The patient remained febrile, with hemoglobin levels
ranging between 5 and 6 g/dL.
At day 20, CMV antigenemia, viremia, and blood PCR
were negative. Considering the poor clinical response to
antiviral treatment, we hypothesized an immunologic
pathogenetic mechanism of hemolytic anemia, and ster-
oid therapy with methylprednisolone, 1 mg/kg/day i.v.
was started. Gancyclovir therapy was continued.
The clinical condition of the patient improved.
At discharge (day 30), blood examinations showed
RBCs, 276,0000/mm3; Hb, 9.7 g/dL; reticulocytes, 5.4%;
haptoglobin, 105 mg/dL (n.v., 40 to 130). Treatment
with 900 mg/qd oral valganciclovir, and oral prednisone,
1 mg/kg/day, was continued.
At day 90, the patient was asymptomatic with an
hemoglobin level of 12.2 per deciliter. Valganciclovir
and steroids were stopped.
Discussion
This is an uncommon case of severe hemolytic anemia
during primary CMV in an immunocompetent patient.
An immunologic mechanism was supported by the clini-
cal improvement with steroid therapy, whereas the clini-
cal picture remained unvaried during antiviral therapy
alone. This hypothesis was indirectly confirmed by the
demonstration of the abnormal immunologic activation
occurring during CMV infection (that is, the positivity
of the serologic tests for parvovirus B19 and EBV,
together with the negativity of blood PCR for these two
viruses), which was likely interpreted as a cross-reaction.
An interesting finding in our case was the negativity of
the Coombs test. A positive Coombs test could have
helped in identifying an autoimmune mechanism, thus
making the patient eligible for early steroid therapy.
However, the presence of an underlying autoimmune
mechanism could not be ruled out, based only on the
negativity of Coombs test. The literature provides
Table 1 Hemolytic anemia during acute cytomegalovirus infection in adult immunocompetent patients: data from the
literature
Authors/Year Number of patients Coombs test BT Steroids Anti-CMV therapy Outcome
Rafailidis M./2008 [7] 5* NS NS NS NS Cured
Veldhuis et al./2004 [5] 1 Neg No No No Cured







Van Spronsen D. et al./1996 [2] 1 Neg No Yes Yes Cured
Gavazzi G. et al./1999 [1] 1 Pos No Yes Yes Cured







BT, blood transfusion; Neg, negative; NS, not specified.
*Among 290 apparently immunocompetent patients with severe cytomegalovirus infection who were included in a review.
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evidence of the onset of hemolysis in patients with nega-
tive Coombs test during CMV infection [5]. In our spe-
cific case, the presence of cold agglutinins may be a
possible explanation for the onset of hemolysis.
We performed a review of the literature by PubMed
for relevant articles regarding hemolytic anemia during
acute CMV infection in apparently immunocompetent
individuals, published between 1980 and 2008. Only 12
cases have been reported (Table 1). Rafailidis et al. [7]
performed a systematic review that included 290 immu-
nocompetent patients with severe clinical manifestations
of CMV infection, of whom only five were found to
have hemolytic anemia.
Among the 12 cases reported in the literature,
the Coombs test was positive in four, negative in three,
and was not specified for the remaining five patients
(Table 1).
Bonnet et al. [8] described 115 patients with acute
CMV infection. Twenty-three patients (20%) had hemo-
lytic anemia; however, the authors did not distinguish
whether the hemolysis was secondary to hypersplenia or
directly connected to the CMV infection; thus this study
was not reported in Table 1.
Regarding therapeutic management, two patients were
treated with steroids and anti-CMV therapy (one of
whom also had blood transfusions); two received only
steroid therapy; three patients were not given any speci-
fic treatment; and for the remaining five patients, the
treatment was not specified. Interestingly, the prognosis
was favorable in all cases, including those patients who
did not receive steroids and/or antiviral therapy. One of
those cases had a clinical history similar to that of our
patient [5], with a hemoglobin level that reached 5.1 g/
dL, and the patient experienced a full and spontaneous
recovery without additional medications.
As is evident in the literature, no conclusive state-
ments regarding specific treatment of hemolytic anemia
during acute CMV infection in immunocompetent
patients can be made.
In our opinion, although steroid and specific antiviral
therapy was given in our patient, the policy of “wait and
see” in the presence of hemolytic anemia without severe
manifestations during CMV infection in an immuno-
competent patient could be justified.
Conclusions
Clinicians should consider CMV infection in the differ-
ential diagnosis of hemolytic anemia in immunocompe-
tent adults. The true incidence of this complication may
be underestimated, because CMV serology may not be
routinely obtained in patients with hemolysis. Possible
therapeutic options include antiviral therapy and ster-
oids, although the best treatment strategy is still
controversial.
Randomized controlled trials are needed for conclu-
sive answers regarding the specific treatment of hemoly-
tic anemia due to CMV infection.
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